openPR Logo
Press release

TransAsia Bio-Medicals donates hematology analyzer to Sri Sathya Sai Institute of Higher Medical Sciences, Bengaluru

03-27-2019 06:39 PM CET | Health & Medicine

Press release from: PRHUB INTEGRATED MARKETING COMMUNICATION PRIVATE LIMITED

/ PR Agency: PRHUB Integrated Marketing Communication Pvt. Ltd.
Press release for immediate publication

TransAsia Bio-Medicals donates hematology analyzer to Sri Sathya Sai Institute of Higher Medical Sciences, Bengaluru

Bengaluru, March 25, 2019: Transasia Bio-Medicals Ltd., India’s Leading In-vitro Diagnostic Company has donated its newly launched hematology analyzer, H 360 to Sri Sathya Sai Institute of Higher Medical Sciences, Bengaluru. This is in support of the institute’s most urgent need for essential instruments, for more precise diagnosis, faster treatment and improved outcomes. The H 360, is a three part differential fully automated hematology analyzer, developed at Transasia’s European subsidiary - Erba Europe. With its ability to detect CBC and WBC Differential with high precision and accuracy, H 360 will be useful in screening of anemia & its causes, indicating the presence of hemoglobinopathies, helping in detection of cytopenia, septicemia or leukemia and platelet related pathologies & disorders. Transasia has been closely associated with the institute for the last 25 years, supporting the institute with various dedicated initiatives such as blood donation drives, health check-up camps, providing required equipment and contributing to fund-raising activities. Alongwith the H 360, Transasia also announced the launch of two more 5 Part Differential Fully Automated Hematology analyzers, H 560 and Elite 580. Together this entire new range, with a host of features will help institutions, clinicians and laboratory technologists offer accurate diagnosis. The launch of these analyzers has come at an apt time, as Transasia celebrates its 40th anniversary.

In his comments, Suresh Vazirani, Chairman & Managing Director, Transasia Bio-Medicals Ltd. said, “Am immensely proud of Transasia’s continuing association with Sri Sathya Sai Institute of Higher Medical Sciences. The impact of the good work done by the institute has benefited not only the poor patients in Bengaluru but also those from the nearby areas. At Transasia, we believe in operating with a higher purpose, with an unwavering focus on ensuring equitable and affordable access to diagnostic facilities. This latest version of the instrument will be able to offer four more extra parameters for in-depth analysis.”

Added, Dr. Sundaresh D C., Director, Sri Sathya Sai Institute of Higher Medical Sciences, “We are thankful to Mr. Vazirani and Transasia for supporting us with the analyzer. Transasia has a long-standing legacy of offering

quality and affordable diagnostic solutions and I am sure that the additional parameters being offered by this new analyzer will provide more diagnostic value and aid in early and accurate diagnosis.”

About Transasia Bio-Medicals Ltd. :
Founded in 1979, Transasia Bio-Medicals Ltd., India’s Leading In-vitro Diagnostic Company offers products and solutions in Biochemistry, Hematology, Coagulation, ESR, Immunology, Urinalysis, Critical Care, Diabetes Management, Microbiology and Molecular Diagnostics. Transasia provides doctors and patients with reliable, affordable and innovative Medical Diagnostic Systems, with an impressive install base of above 65,000 equipment across India. It has a vast network of the more than 250 service engineers, 400+ sales and marketing team, 23 zonal offices and 350+ distributors. It is the first Indian company to manufacture and export blood analyzers and reagents, in the 1990s. Today, Transasia’s indigenous research has resulted in development of state of the art, ‘Make in India’ products and technologies, enabling its products to be among the best in the world. All along its journey spanning more than four decades, Transasia has been recognized for its commitment to healthcare. It has been conferred ‘India Medical Device - Export Company of the Year’ and the ‘Global Growth Company-2014’ by the World Economic Forum amongst many others. Headquartered in Mumbai, Transasia is a part of the global Transasia-Erba group. The group has spread its footprint across USA, UK, Germany, Czech Republic, France, Italy, Russia and Turkey through various acquisitions. Transasia-Erba Group’s production sites in India, Czech Republic and USA and R&D centres in France, UK, India and Czech Republic form a hub for indigenous manufacturing of world class deliverables. Today, the group serves millions across 100 countries. For further information, kindly visit www.erbamannheim.com
For editorial queries only contact:
Divya, PRHUB I Mobile: +917353270018 I divya@prhub.com / Sanjay, PRHUB I Mobile: +919632387860 I sanjay@prhub.com

Founded in 1979, Transasia Bio-Medicals Ltd., India’s Leading In-vitro Diagnostic Company offers products and solutions in Biochemistry, Hematology, Coagulation, ESR, Immunology, Urinalysis, Critical Care, Diabetes Management, Microbiology and Molecular Diagnostics.

Comapny: PRHUB Integrated Marketing Communication Pvt. Ltd.
Postal Address: #22, Samson Arcade, Ground Floor, Andree Road, Shanthinagar, Bangalore-560027.
Contact Number: 735370018.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release TransAsia Bio-Medicals donates hematology analyzer to Sri Sathya Sai Institute of Higher Medical Sciences, Bengaluru here

News-ID: 1674139 • Views: 591

More Releases from PRHUB INTEGRATED MARKETING COMMUNICATION PRIVATE LIMITED

Sami Labs Appoints Neeraja Shetty as its Chief Executive Officer
Press Release Sami Labs Appoints Neeraja Shetty as its Chief Executive Officer Bengaluru, March 02, 2020: Sami-Sabinsa Group, a pioneer & global leader in health science, today announced the appointment of Ms. Neeraja Shetty as the Chief Executive Officer of Sami Labs (a part of Sami-Sabinsa Group). As the CEO, Neeraja will oversee and drive key functions of strategy, operations, supply chain, finance and new projects to help achieve the ambitious growth
GLOBAL IT AUTOMATION MAJOR APPVIEWX ANNOUNCES EXPANSION OF INDIA OPERATIONS ACRO …
Press Release GLOBAL IT AUTOMATION MAJOR APPVIEWX ANNOUNCES EXPANSION OF INDIA OPERATIONS ACROSS COIMBATORE, BANGALORE AND CHENNAI Confident of achieving 100% Year-on-Year growth Coimbatore, January 7, 2020: Global pioneer in low-code network automation technology, AppViewX, today announced plans to expand its India operations across Coimbatore, Bangalore and Chennai. The company’s India operations will support sales and customer delivery, besides continued R&D on its innovative platform to enable complete IT automation. AppViewX’s
Microchip Solves Interoperability Challenges of Delivering up to 90 Watts of Pow …
Microchip Solves Interoperability Challenges of Delivering up to 90 Watts of Power Over Ethernet Wiring Company’s Power over Ethernet (PoE) offering enables both pre-standard and IEEE® 802.3bt-2018-compliant devices to be powered within existing Ethernet infrastructure New Delhi, October 28, 2019 — As the industry adopts the latest generation of PoE technology for managing data and power over a single Ethernet cable, users face the challenge of making pre-standard powered devices (PDs) work
Preserve Legacy Low Pin Count (LPC) Investments with the Industry’s First Comm …
Preserve Legacy Low Pin Count (LPC) Investments with the Industry’s First Commercial eSPI to LPC Bridge Device allows industrial computing developers to integrate the eSPI standard in existing equipment, minimizing development costs and extending product lifecycles New Delhi, May 29, 2019 — As the industrial computing industry transitions from Low Pin Count (LPC) to enhanced Serial Peripheral Interface (eSPI) bus technology, developers face high development costs to update existing equipment

All 5 Releases


More Releases for Transasia

Transasia Bio-Medicals’ international hematology range backed by European R&D …
Press release for immediate publication: Transasia Bio-Medicals’ international hematology range backed by European R&D is now in Tamil Nadu; to base its next hi-tech manufacturing facility in the South Priced 25% below comparable options, new range to make world-class diagnostics affordable for masses Chennai April 27, 2019: Transasia Bio-Medicals Ltd., India's No. 1 In-vitro Diagnostic (IVD) Company and among the leading global players focused on emerging markets, today as part of its 40th
Transasia-Erba Groups’ international hematology range backed by European R&D, …
Transasia-Erba Groups’ international hematology range backed by European R&D, now in Ahmedabad Eyes 500 crores in FY2020-21 from hematology in Indian market; Gujarat is home to a significantly large number of thalassemia patients, priced 25% below comparable options, new range to make world-class diagnostics affordable for them Ahmedabad, May 11, 2019: Transasia-Erba Group, India's No. 1 In-vitro Diagnostic (IVD) Company and among the leading global players focused on emerging markets, today
Transasia-Erba Group’s international hematology range backed by European R&D i …
Transasia-Erba Group’s international hematology range backed by European R&D is now in Kerala; eyes 300 crore India revenues from new hematology range in FY 2019-20 Priced 25% below comparable options new range to make diagnostics affordable for masses; will also aid early/accurate diagnosis of cancer & other blood disorders, a growing concern for Kerala Kochi, May 4, 2019: Transasia-Erba Group, India's No. 1 In-vitro Diagnostic (IVD) Company and among the leading global
Transasia Bio-Medicals’ international hematology range backed by European R&D …
Press release for immediate publication Transasia Bio-Medicals’ international hematology range backed by European R&D is now in Chandigarh; eyes 300 crores in FY2020-21 from hematology in Indian market Among India’s top 5 cities in per capita income, Chandigarh is a natural market for European technology; priced 25% below comparable options, new range to make world-class diagnostics affordable for masses Chandigarh, April 27, 2019: Transasia Bio-Medicals Ltd., India's No. 1 In-vitro Diagnostic (IVD)
Coagulation Reagent Market - Global Industry Analysis & Outlook 2025 : Sclavo, R …
ResearchMoz presents professional and in-depth study of "Global Coagulation Reagent Market Insights, Forecast to 2025". This research assessment offers a clear insight about the influential factors that are expected to transform the global market in the near future. This report studies the global market size of Coagulation Reagent in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of
Global ESR Analyzers Market 2017 - Transasia Bio-Medicals, Alifax, Streck, HemaT …
Erythrocyte Sedimentation Rate (ESR) can be defined as the rate at which red blood cells or erythrocytes sediment in a period of one hour. ESR is usually measured in millimeter per hour (mm/hr) and a value above 100 mm/hr indicates a disease condition, such as a disease that causes inflammation, active infection, cancer, heart disease, kidney disease, blood disease, diabetes, and collagen vascular disease. Scope of the Report: This report focuses on